Squarepoint’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$309K Buy
2024
Q4
$139K Buy
2024
Q3
$56.5K Sell
2024
Q2
$161K Buy
2024
Q1
$22.4K Buy
2021
Q1
Sell
2020
Q4
$80K Sell
2020
Q3
$173K Buy